| scholarly article | Q13442814 |
| P50 | author | Serena Pavoni | Q90584648 |
| Ferid Nassor | Q90584652 | ||
| Steve Cottin | Q90584657 | ||
| Frank Yates | Q90584659 | ||
| P2093 | author name string | Jean-Philippe Deslys | |
| Jacqueline Mikol | |||
| Aloïse Mabondzo | |||
| Rafika Jarray | |||
| Anne-Cécile Guyot | |||
| Jessica Rontard | |||
| P2860 | cites work | Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers | Q22251089 |
| How common are the "common" neurologic disorders? | Q22306182 | ||
| Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes | Q48169692 | ||
| The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia | Q48360091 | ||
| Lessons from a failed γ-secretase Alzheimer trial. | Q48449453 | ||
| Immunohistochemical expression of prion protein (PrPC) in the human forebrain during development. | Q48476945 | ||
| Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease. | Q50322422 | ||
| Modeling amyloid beta and tau pathology in human cerebral organoids. | Q60017547 | ||
| Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure | Q24004552 | ||
| Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio | Q24298670 | ||
| Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease | Q24670696 | ||
| Alzheimer's in 3D culture: challenges and perspectives | Q26801081 | ||
| Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes | Q27324311 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| Aftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease? | Q28828789 | ||
| A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 | ||
| Cerebral organoids model human brain development and microcephaly | Q28973619 | ||
| Generation of cerebral organoids from human pluripotent stem cells | Q28973621 | ||
| Alzheimer's disease: the amyloid cascade hypothesis | Q29547160 | ||
| Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective | Q29614702 | ||
| Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells | Q29615870 | ||
| Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders | Q30278015 | ||
| The prion protein in human neurodegenerative disorders | Q31104544 | ||
| Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease | Q33757721 | ||
| Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity | Q34100175 | ||
| Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis | Q34480339 | ||
| Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain | Q34868772 | ||
| Probing the secrets of Alzheimer's disease using human-induced pluripotent stem cell technology | Q35064977 | ||
| Comparison and optimization of hiPSC forebrain cortical differentiation protocols | Q35233519 | ||
| Analysis of embryoid bodies derived from human induced pluripotent stem cells as a means to assess pluripotency | Q35893663 | ||
| Aging and reprogramming: a two-way street | Q36518127 | ||
| Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape | Q37138581 | ||
| Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly | Q37391300 | ||
| Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease | Q37489141 | ||
| Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions | Q37979824 | ||
| Animal models of Alzheimer disease: historical pitfalls and a path forward | Q38209146 | ||
| Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead. | Q38559734 | ||
| NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein | Q38562137 | ||
| Generating CNS organoids from human induced pluripotent stem cells for modeling neurological disorders | Q38659708 | ||
| An update on stem cell biology and engineering for brain development | Q38735486 | ||
| Organoids as an in vitro model of human development and disease. | Q38748913 | ||
| Epigenetic Mechanisms of Longevity and Aging. | Q38926028 | ||
| A three-dimensional human neural cell culture model of Alzheimer's disease | Q42069680 | ||
| Cell diversity and network dynamics in photosensitive human brain organoids. | Q42615577 | ||
| The prion protein gene: a role in mouse embryogenesis? | Q43408865 | ||
| Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness | Q45736205 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| organoid | Q11293125 | ||
| P304 | page(s) | e0209150 | |
| P577 | publication date | 2018-12-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes | |
| P478 | volume | 13 |
| Q98945390 | Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020) |
| Q89963823 | Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease |
| Q92000754 | Modeling and Targeting Alzheimer's Disease With Organoids |
| Q97066898 | Retinal and Brain Organoids: Bridging the Gap Between in vivo Physiology and in vitro Micro-Physiology for the Study of Alzheimer's Diseases |
| Q93075253 | Screening of pure synthetic coating substrates for induced pluripotent stem cells and iPSC-derived neuroepithelial progenitors with short peptide based integrin array |
| Q63740571 | The Use of Pluripotent Stem Cell-Derived Organoids to Study Extracellular Matrix Development during Neural Degeneration |
Search more.